SUSANA MUNOZ ORTIZ: Open Payments
NPI 1316609910 · GRAND PRAIRIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 20 payments from 10 companies in 2025. Trend: 2023 $297 · 2024 $396 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $103 |
| Novo Nordisk Inc | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Organon LLC | 2 | $33 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $13 |
Products named: JARDIANCE, UZEDY, NEXPLANON, MOUNJARO, Ozempic, PAXLOVID, FARXIGA, TZIELD.
Industry payments across TX — which companies pay providers there.
